Describing himself as a “glass half-full” type of person, Steve Hoffart, owner of Magnolia Pharmacy in Magnolia, Texas, is bullish on pharmacy’s future, even with the well-documented challenges facing the profession. Hoffart started his pharmacy in 2002 with three employees and he now has 35 who, he says, deserve the lion’s share of credit for his success. Is Magnolia a template for pharmacy’s future? Check out the feature story in December’s issue of America’s Pharmacist® to find out.
NCPA represented at annual FDA listening session on compounding ncpa.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ncpa.org Daily Mail and Mail on Sunday newspapers.
On Jun 15, NCPA staff Steve Postal and NCPA members Steve Hoffart and Cheri Garvin will participate in the FDA’s annual listening session by speaking about compounding. Hoffart and Garvin will each be giving 5-minute statements.
On June 15, NCPA will be represented at FDA’s annual listening session on compounding by NCPA staff Steve Postal and NCPA members and meeting presenters Steve Hoffart and Cheri Garvin. NCPA submitted its written statement for the record ahead of the listening session on compounding, covering concerns with GFI #256 (compounding animal drugs from bulk substances), patient access to compounded bioidentical hormone therapy, drug shortages, and adverse event reporting.
Despite a scarcity, several independent American pharmacies have ignored Ozempic shortages. (Photo : JOEL SAGET/AFP via Getty Images)This photograph taken on February 23, 2023, in Paris, shows the anti-diabetic medication "Ozempic" (semaglutide) made by Danish pharmaceutical company "Novo Nordisk".